Description
About
Adareesahacharadi Kashayam is a classical Ayurvedic herbal decoction used primarily for respiratory disorders, cough, and cold. It is a potent formulation that balances Kapha and Vata doshas and is traditionally prescribed in bronchitis, asthma, chronic cough, and throat infections. The herbal combination helps relieve congestion, improve breathing, and strengthen respiratory function.
Uses
-
Manages cough, cold, and throat irritation
-
Supports treatment of bronchitis and asthma
-
Reduces congestion and mucus formation
-
Strengthens respiratory system and lung function
-
Enhances immunity against respiratory infections
Benefits
-
Acts as a natural expectorant and bronchodilator
-
Provides relief from Vata-Kapha imbalances in the respiratory system
-
Helps in reducing inflammation of airways
-
Supports overall lung health and breathing efficiency
-
Safe for long-term use under Ayurvedic supervision
Different Names in Different Languages
-
Tamil: அதரீசஹாசராதி கஷாயம்
-
Hindi: अदरीसहचारादि कषाय
-
Telugu: అదరీసహచారాది కషాయం
-
Kannada: ಅದರೀಸಹಚಾರಾದಿ ಕಷಾಯ
-
Malayalam: ആദരീസാഹചരാദി കഷായം
-
English: Adareesahacharadi Kashayam / Ayurvedic Herbal Decoction
Key Ingredients (Common)
-
Adarisa (Hedyotis corymbosa) – anti-inflammatory and respiratory tonic
-
Chavya (Piper retrofractum) – improves digestion, Kapha reduction
-
Pippali (Long pepper) – expectorant, bronchodilator
-
Other herbs that support respiratory health and Kapha-Vata balance
Dosage & Administration
-
Adults: 15–30 ml of decoction twice daily with equal quantity of warm water
-
Children: 5–10 ml twice daily (under physician supervision)
-
Take after meals for better absorption and efficacy
-
Can be sweetened with honey if needed
Precautions
-
Use under Ayurvedic supervision, especially for children, pregnant, and lactating women
-
Avoid consumption on an empty stomach if prone to acidity
-
Store in a cool, dry place; consume fresh decoction
-
Consult a physician if symptoms persist or worsen

























Reviews
There are no reviews yet.